While we cannot rule out the possibility that these compounds might have other targets that are responsible for or contributing to the improvement of diabetes, we consider such a possibility unlikely as these two different compounds would have most likely engaged in different unknown targets if not the known target IRE1α. This evidence concerns the gene ERN1 and diabetes mellitus.